Prostate cancer is a common disease in modern, developed societies and has a high incidence and mortality.
High-density lipoprotein cholesterol (HDL-C) has recently received much attention as a possible risk marker of prostate cancer development and prognosis. In the present article, we summarized findings from epidemiologic studies of the association between HDL-C and prostate cancer. Low HDL-C level was found to be a risk and prognostic factor of prostate cancer in several epidemiologic studies, although the overall linkage between HDL and prostate cancer has not been definitively established. The mechanisms for this association remain uncertain; however, limited data from experimental studies imply a possible role of HDL in the pathophysiology of prostate cancer. More epidemiologic research, in combination with experimental studies, is needed in this field.
Written by:
Kotani K, Sekine Y, Ishikawa S, Ikpot IZ, Suzuki K, Remaley AT. Are you the author?
Cardiopulmonary Branch, National Heart Lung and Blood Institute, National Institutes of Health.
Reference: J Epidemiol. 2013 Sep 5;23(5):313-9.
doi: 10.2188/jea.JE20130006
PubMed Abstract
PMID: 23985823
UroToday.com Investigative Urology Section
